Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIPTORELIN for Benign prostatic hyperplasia: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 9 adverse event reports in the FDA FAERS database where TRIPTORELIN was used for Benign prostatic hyperplasia.

Most Reported Side Effects for TRIPTORELIN

Side Effect Reports % Deaths Hosp.
Off label use 545 10.1% 13 67
Death 362 6.7% 359 36
Ovarian hyperstimulation syndrome 356 6.6% 3 307
Needle issue 242 4.5% 6 2
Disease progression 203 3.8% 20 6
Product dose omission issue 178 3.3% 6 27
Drug ineffective 175 3.3% 9 13
Weight increased 167 3.1% 5 13
Hot flush 153 2.8% 7 20
Headache 145 2.7% 0 21
Injection site pain 138 2.6% 0 10
Inappropriate schedule of product administration 131 2.4% 29 55
Incorrect dose administered 131 2.4% 4 6
Syringe issue 128 2.4% 0 1
Vaginal haemorrhage 125 2.3% 3 12

Other Indications for TRIPTORELIN

Product used for unknown indication (1,867) Prostate cancer (1,485) Precocious puberty (277) Breast cancer (235) Assisted reproductive technology (175) Prostate cancer metastatic (146) Gender dysphoria (136) In vitro fertilisation (129) Ovulation induction (73) Off label use (61)

Other Drugs Used for Benign prostatic hyperplasia

TAMSULOSIN (3,156) TADALAFIL (1,154) FINASTERIDE (1,104) DUTASTERIDE (1,004) ALFUZOSIN (849) SILODOSIN (628) DUTASTERIDE\TAMSULOSIN (313) DOXAZOSIN (219) HERBALS\SAW PALMETTO (181) MIRABEGRON (93)

Related Pages

TRIPTORELIN Full Profile All Benign prostatic hyperplasia Drugs TRIPTORELIN Demographics TRIPTORELIN Timeline